In the Know: Healthcare News for March 7, 2022 – Medical Alley Association

In the Know: Healthcare News for March 7, 2022

Arden Hills’ Intricon Selling for $241 Million to Private-Equity Group

RQM+ Appoints Life Science Executive Margaret Keegan as New CEO

Cardiovascular Systems, Inc. Appoints Jeffery W. Chambers, M.D., as Chief Medical Officer

LEAH Labs Awarded NIH Phase I SBIR Grant

Saluda Medical Announces $125M Equity Financing Led by Redmile Group LLC and New Investors Fidelity Management & Research Company LLC and T. Rowe Price Associates, Inc.

Kavira Health Announces Acceptance of Medicare Patients

ICU Medical Beats The Street in Q4, Posts Full-Year Guidance

Baker to Retire From Ecolab Board

Pear Therapeutics Advances in Efforts to Get CMS to Cover Prescription Digital Therapeutics

Bright Health Group Names Leading Healthcare Expert to Board

Nuwellis, Inc. Announces Fourth Quarter and Full Year 2021 Financial Results

Mayo Clinic’s 2021 Achievements Affirm ‘Bold. Forward.’ Strategic Vision, Staff Dedication

Expanding Access to Cell Therapies with a Patient-Centric Focus

Introducing the Minne Inno Madness Bracket

Bio-Techne Announces Exclusive Development and License Agreement with Thermo Fisher Scientific for ExoTRU® Kidney Transplant Rejection Assay

Medibio Adds Health IT & Medical Device Expertise with the Appointment of Dr. Matt Mesnik as Non-Executive Director

Parkview Partners with Best Buy

Miromatrix Names Jim Douglas as New Chief Financial Officer

Piper Sandler Announces Final Closing for Piper Heartland Healthcare Crossover Fund I

Startups Get a Leg Up with Mayo Clinic Platform Accelerate

NICE Recommends ICU Medical’s ClearGuard HD

GRIP Molecular Announces BLUE KNIGHT™ Acceptance

GRIP Molecular Logo

Keep your finger on the pulse of Medical Alley from anywhere with the ALLEY NEWSLETTER